SGLT2 inhibitors: Paradigm shift from diabetes care to metabolic care—An Indian perspective

SGLT2 inhibitors: Paradigm shift from diabetes care to metabolic care—An Indian perspective

The prevalence and burden of diabetes are on the rise in India, making it 'the diabetes capital of the world'. Comorbidities such as obesity, cardiovascular (CV) complications, chronic kidney disease (CKD), non-alcoholic fatty liver disease (NAFLD), and neurodegenerative diseases are commo...

Full description

Bibliographic Details
Main Authors: K M Prasanna Kumar, A G Unnikrishnan, Pankaj Jariwala, Ashwani Mehta, Richa Chaturvedi, Sagar Panchal, Preet Lakhani, Rachana Acharya, Jitendra Dixit
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
diabetes
metabolic care
obesity
organ protection
sglt inhibitors
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2024;volume=28;issue=1;spage=11;epage=18;aulast=Prasanna

Internet

http://www.ijem.in/article.asp?issn=2230-8210;year=2024;volume=28;issue=1;spage=11;epage=18;aulast=Prasanna

Similar Items